Meeting
2020 ASCO Virtual Scientific Program
Outcome of patients with breast cancer and a germline BRCA mutation in a prospective cohort.
Authors
Banu Arun
The University of Texas MD Anderson Cancer Center, Houston, TX
Banu Arun , Angelica Gutierrez Barrera , Rachel M. Layman , Stephen K. Gruschkus , Isabelle Bedrosian , Constance T. Albarracin , Carlos Hernando Barcenas , Vicente Valero , Jennifer Keating Litton , Debu Tripathy
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Risk Reduction, and Genetics
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Genetics
Citation
J Clin Oncol 38: 2020 (suppl; abstr 1544)
DOI
10.1200/JCO.2020.38.15_suppl.1544
Abstract #
1544
Poster Bd #
36
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A population-based study of BRCA breast cancer incidence and prognosis in the Italian Emilia Romagna region: The MUTina study.
First Author: Laura Cortesi
Poster
2022 ASCO Annual Meeting
Detection of presumed germline pathogenic variants of hereditary breast cancer predisposition genes in circulating tumor DNA: SCRUM-Japan MONSTAR-SCREEN.
First Author: Masaya Hattori
Poster
2022 ASCO Annual Meeting
Comprehensive whole-exome and transcriptome profiling to identify actionable alterations associated with response to PARP inhibitors in breast cancer.
First Author: Susan M. Dombrowski
Poster
2019 ASCO Annual Meeting
Brain metastasis in patients with hereditary BRCA-mutated invasive breast cancer.
First Author: Haven Garber